Targeting PERK to counteract histone lactylation could improve immunotherapy for GBM.82 Chronic stress can advance GBM by reducing immune cells in tumors, especially M1 macrophages and CD8+ T cells. This evidence concerns the gene EIF2AK3 and glioblastoma.